Rovin Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$402K Buy
1,943
+273
+16% +$54K 0.11% 139
2025
Q3
$310K Buy
1,670
+315
+23% +$54K 0.09% 171
2025
Q2
$207K Buy
+1,355
New +$208K 0.06% 182
2023
Q1
Sell
-1,204
Closed -$213K 134
2022
Q4
$213K Sell
1,204
-27
-2% -$4.66K 0.11% 119
2022
Q3
$201K Buy
1,231
+6
+0.5% +$1.01K 0.12% 116
2022
Q2
$217K Buy
1,225
+65
+6% +$11.6K 0.15% 108
2022
Q1
$206K Buy
+1,160
New +$197K 0.11% 114

Other funds holding JNJ

Rovin Capital's JNJ Position: Q4 2025 in Review

Rovin Capital increased its Johnson & Johnson (JNJ) stake by 16% in Q4 2025, buying an estimated $54K and bringing the position to 1,943 shares worth $402K. The position accounts for 0.11% of the portfolio, ranked #139.

Rovin Capital first reported a position in JNJ in Q1 2022 and has held it in 7 quarters since. 4,520 funds tracked by Wall St. Rank hold JNJ as of Q4 2025.

  • Rovin Capital held 1,943 shares of Johnson & Johnson worth $402K as of Q4 2025.
  • Rovin Capital bought 273 Johnson & Johnson shares in Q4 2025, an estimated $54K.
  • Johnson & Johnson made up 0.11% of Rovin Capital's portfolio in Q4 2025, its #139 holding.
  • Rovin Capital first reported a position in Johnson & Johnson in Q1 2022 and has held it in 7 quarters since.
  • 4,520 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2025.

Based on Rovin Capital's 13F filing for Q4 2025, filed 9 Feb 2026.